GAM Holding’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,927
Closed -$909K 363
2021
Q1
$909K Sell
5,927
-725
-11% -$98.5K 0.04% 243
2020
Q4
$835K Hold
6,652
0.05% 195
2020
Q3
$675K Sell
6,652
-105
-2% -$10.7K 0.04% 260
2020
Q2
$658K Sell
6,757
-683
-9% -$63.6K 0.04% 262
2020
Q1
$618K Buy
7,440
+1,478
+25% +$144K 0.04% 259
2019
Q4
$663K Buy
5,962
+1,947
+48% +$200K 0.03% 312
2019
Q3
$398K Sell
4,015
-3,587
-47% -$356K 0.02% 650
2019
Q2
$754K Sell
7,602
-1,191
-14% -$114K 0.03% 568
2019
Q1
$970K Buy
8,793
+4,484
+104% +$469K 0.04% 440
2018
Q4
$396K Sell
4,309
-1,385
-24% -$140K 0.02% 604
2018
Q3
$627K Buy
5,694
+1,121
+25% +$117K 0.02% 610
2018
Q2
$427K Buy
+4,573
New +$394K 0.01% 703

Other funds holding PRAH

GAM Holding's PRAH Position: Q2 2021 in Review

GAM Holding sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 5,927 shares — an estimated $909K sold.

GAM Holding first reported a position in PRAH in Q2 2018 and held it in 12 quarters. The position peaked at $970K in Q1 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • GAM Holding reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • GAM Holding sold 5,927 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $909K.
  • GAM Holding first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 12 quarters.
  • GAM Holding's PRA Health Sciences, Inc. position peaked at $970K in Q1 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on GAM Holding's 13F filing for Q2 2021, filed 9 Aug 2021.